{"id":3680,"date":"2018-01-17T16:55:24","date_gmt":"2018-01-17T21:55:24","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3680"},"modified":"2018-01-17T16:55:24","modified_gmt":"2018-01-17T21:55:24","slug":"secondaries-announced-1-17-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1-17-18\/","title":{"rendered":"Secondaries Announced 1.17.18"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

 <\/p>\n

Company: Arrowhead Pharmaceuticals, Inc.<\/strong>
\nSymbol: ARWR
\nPrice: Last Trade $5.72
\nTrade Date: 1\/18
\nShares: 7 million ($40 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Jefferies, Barclays, Cantor Fitzgerald
\nDescription: Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Agios Pharmaceuticals, Inc.<\/strong>
\nSymbol: AGIO
\nPrice: Last Trade $70.33
\nTrade Date: 1\/19
\nShares: 5.7 million ($400m cash raise)
\nUnderwriter(s): J.P. Morgan, Goldman Sachs, Cowen and Company
\nDescription: Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Innovative Industrial Properties<\/strong>
\nSymbol: IIPR
\nPrice: Last Trade $31.30
\nTrade Date: 1\/18
\nShares: 1 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Ladenburg Thalmann, Compass Point Research, National Securities
\nDescription: Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
\nRating =Subscription Needed<\/a><\/strong><\/p>\n

Company: Paratek Pharmaceuticals, Inc.<\/strong>
\nSymbol: PRTK
\nPrice: Last Trade $17.67
\nTrade Date: 1\/18
\nShares: 2.9 million ($50m cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): BTIG
\nDescription: Paratek Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics based upon tetracycline chemistry.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Eagle Point Credit Company, Inc.<\/strong>
\nSymbol: ECC
\nPrice: Last Trade $19.13
\nTrade Date: 1\/18
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nShares: 1.75 million
\nUnderwriter(s): Keefe Bruyette & Woods, UBS
\nDescription: Eagle Point Credit is a non-diversified, closed-end management investment company.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Playa Hotels and Resorts N.V. – Block
\nSymbol: PLYA
\nPrice: Last Trade $11.31
\nTrade Date: 1\/18
\nShares: 6.0 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Morgan Stanley
\nDescription: Playa Hotels & Resorts N.V. owns, operates, and develops all-inclusive resorts in prime beachfront locations in various vacation destinations in Mexico and the Caribbean.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[896,1450,815,1449,1448,338],"class_list":["post-3680","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-agio","tag-arwr","tag-ecc","tag-iipr","tag-plya","tag-prtk"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3680"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3680\/revisions"}],"predecessor-version":[{"id":3681,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3680\/revisions\/3681"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}